Given the increasing number of licensing deals and the expected approval of multiple mid-late stage candidates, the encapsulated cell therapies and encapsulation technologies market is anticipated to evolve at a rapid pace over the next decade, predicts R

Pharmaceuticals

Roots Analysis has done a detailed study on Cell Encapsulation: Focus on Therapeutics and Technologies, 2019-2030 ... Read more

Submitted by Roots_Analysis on 2020-09-08 10:08.

The “Cell Therapy Manufacturing Market (3rd Edition), 2019-2030

Market-Research

Key Inclusions

A detailed review of the overall landscape of companies that are engaged in the manufacturing of cell-based therapies, including information on the type of cells manufactured (including immune cells (including T cells, dendritic cells, NK cells),

Submitted by Roots_Analysis on 2020-09-08 09:29.

More than 100 industry players and over 60 non-industry players currently claim

Market-Research

Owing to various reasons, the demand for cell therapies is anticipated to increase over the coming years. Therefore, both therapy developers and contract service providers may need to strengthen their capabilities and expand available capacity. In this context, automation is expected to be a key ... Read more

Submitted by Roots_Analysis on 2020-09-08 09:25.

The cell therapy manufacturing market is projected to grow at an annualized rate of >16.5%, till 2030

Market-Research

Roots Analysis has done a detailed study on Cell Therapy Manufacturing Market (3^rd Edition), 2019 - 2030, covering ... Read more

Submitted by Roots_Analysis on 2020-09-08 09:19.

The cell therapy manufacturing market is estimated to reach close to USD 11 Billion by 2030

Market-Research

Manufacturing cell therapies is technically and financially demanding; as a result, despite therapy developers gradually strengthening their in-house expertise, they are also becoming increasingly reliant on contract service providers

Submitted by Roots_Analysis on 2020-09-08 09:15.

Growing at an annualized rate of over 16.5%, the cell therapy manufacturing market

Market-Research

The approval of KYMIRAH®, YESCARTA®, Alofisel® and Zyntelgo® has increased the interest of pharma stakeholders in cell therapies; further, owing to the technical challenges in this field, outsourcing manufacturing operations has become a necessity

Submitted by Roots_Analysis on 2020-09-08 09:10.

The “Encapsulated Cell Therapies and Encapsulation Technologies Market

Market-Research

Key Inclusions

A detailed assessment of the current market landscape of encapsulated cell therapies and affiliated technologies, highlighting various target disease indications, phase of development, encapsulation method, type of cells / API, and route of

Submitted by Roots_Analysis on 2020-09-08 09:06.

More than 45 encapsulated cell therapies and encapsulation technologies

Market-Research

Extensive research on cell encapsulation strategies has enabled the development of a variety of technologies capable of immobilizing / enclosing therapeutic entities within biocompatible matrices / carriers. Such products offer a myriad of advantages, and have demonstrated the capability to ... Read more

Submitted by Roots_Analysis on 2020-09-08 09:01.

Given the increasing number of licensing deals and the expected approval of multiple mid-late stage candidates

Market-Research

Roots Analysis has done a detailed study on Cell Encapsulation: Focus on Therapeutics and Technologies, ... Read more

Submitted by Roots_Analysis on 2020-09-08 08:57.

The “Cell and Advanced Therapies Supply Chain Management Market, 2020-2030” report features an extensive study of the innovative software solutions that are being used to improve / optimize various supply chain-related processes of cell and advanced thera

Pharmaceuticals

To order this 510+ page report, please visit this link

Key Inclusions

Submitted by Roots_Analysis on 2020-09-07 09:26.

Presently, over 160 innovative, software enabled systems are being used to efficiently manage and streamline various aspects of the complex supply chain of cell and advanced therapies

Pharmaceuticals

The cell and advanced therapies supply chain is complex, with several legacy challenges, such as those related to patient scheduling, resource planning, inventory management, and deliverable tracking. A number of innovative, software-enabled systems are available / under development to ... Read more

Submitted by Roots_Analysis on 2020-09-07 09:25.

Given the cost saving potential across different processes and operations, the cell and advanced therapies supply chain management market is projected to grow at an annualized rate of ~25% rapid till 2030

Pharmaceuticals

Roots Analysis has done a detailed study on Cell and Advanced Therapies Supply Chain Management Market: Focus on Technological Solutions (Cell ... Read more

Submitted by Roots_Analysis on 2020-09-07 09:23.

The “Companion Diagnostics Development Services Market, 2020-2030” report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of diagnostic development services over the next decade. It featu

Market-Research

To order this detailed 320+ page report, please visit this link

Key Inclusions

Submitted by Roots_Analysis on 2020-09-07 09:18.

Over 180 companies from different regions across the globe presently claim to provide services for the development of companion diagnostic tests, claims Roots Analysis

Pharmaceuticals

It is estimated that around 80% of innovator companies rely on external companion diagnostic developers, mostly owing to the lack of the required in-house expertise. On the other hand, there are numerous contract service providers, offering vast portfolios of services for diagnostic test / assay ... Read more

Submitted by Roots_Analysis on 2020-09-07 09:17.

The Companion Diagnostics Development Services Market is projected to grow at an annualized rate of ~5%, till 2030

Market-Research

Roots Analysis has done a detailed report on Companion Diagnostics Development Services Market covering key aspects of the industry and identifying future growth opportunities

To order this 320+

Submitted by Roots_Analysis on 2020-09-07 09:16.

The Companion Diagnostics Development Services Market is estimated to be worth over USD 800 million in 2030, predicts Roots Analysis

Market-Research

In the last couple of years, a record number of personalized therapeutic products were approved in the US, establishing an urgent need for companion diagnostics and causing many drug developers to actively seek external support and expertise

Submitted by Roots_Analysis on 2020-09-07 09:14.

The ‘Global Preventive Vaccines Market, 2020-2030’ report

Market-Research

Key Inclusions

A detailed assessment of the current market landscape, including information on type of developer (industry, non-industry, industry / non-industry), phase of development (phase I, phase I/II, phase II, phase II/III, phase III and preregistration) of

Submitted by Roots_Analysis on 2020-09-04 10:51.

More than 200 preventive vaccines, developed by both industry and non-industry players

Market-Research

Technical advances, especially in the field of biotechnology, have led to the development of several next generation preventive vaccines, including recombinant vaccines, viral vector based vaccines and DNA vaccines, which have been demonstrated to elicit powerful immune responses, resulting in ... Read more

Submitted by Roots_Analysis on 2020-09-04 10:47.

The global preventive vaccines market is projected to be worth USD 94 billion, by 2030, growing at a CAGR of 10.7%, claims Roots Analysis

Market-Research

Roots Analysis has done a detailed report on Global Preventive Vaccines Market, 2020-2030, covering key aspects of the industry and identifying potential ... Read more

Submitted by Roots_Analysis on 2020-09-04 10:43.

The global preventive vaccines market is projected to be worth USD 94 billion by 2030

Market-Research

Although vaccines were solely responsible for the global eradication of smallpox (1980) and polio (2015), several vaccine-preventable diseases, such as measles and mumps, are still a threat; COVID-19 has been recently added to the list

Submitted by Roots_Analysis on 2020-09-04 10:39.

Pages